Product Name Aloeemodin
CAS No.: 481-72-1
Catalog No.: CFN98749
Molecular Formula: C15H10O5
Molecular Weight: 270.2 g/mol
Purity: >=98%
Type of Compound: Anthraquinones
Physical Desc.: Powder
Targets: Calcium Channel | ROS | Beta Amyloid | TGF-β/Smad | MMP(e.g.TIMP) | FAK | VEGFR
Source: The roots of Rheum palmatum L.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $30/20mg
Aloeemodin is an interferon-inducing agent with IC50 of about 1 μg/mL for JEV and of about 0.33 μg/mL for EV71. Aloeemodin has antitumor, neuroprotective, and anti-fibrosis effects, it inhibited β-amyloid aggregation, downregulated the expression of Smad2 mRNA and TGF-β1,TIMP1,and type Ⅰ and Ⅲ collagen proteins,and upregulated the expression of Smad7 mRNA.
Inquire / Order:
Technical Inquiries:
Tel: +86-27-84237783
Fax: +86-27-84254680

1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to:

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Front Pharmacol.2016, 7:460
  • RSC Advances2017, 86
  • Korean Journal of Pharmacognosy2018, 49(4):349-361
  • Drug Invention Today2019, 12(6):1303-1306
  • Viruses.2017, 9(10)
  • United States Patent Application2020, 20200038363
  • J Sci Food Agric.2017, 97(5):1656-1662
  • Saudi Pharm J2020, 10.1016
  • J Agric Food Chem.2019, 67(27):7748-7754
  • British Jou. Med.&Med. Research2014, 1802-1811
  • Emodin

    Catalog No: CFN98834
    CAS No: 518-82-1
    Price: $30/20mg

    Catalog No: CFN96731
    CAS No: 103392-51-4
    Price: Inquiry(

    Catalog No: CFN98848
    CAS No: 521-61-9
    Price: $40/20mg

    Catalog No: CFN89155
    CAS No: 3774-64-9
    Price: Inquiry(

    Catalog No: CFN89152
    CAS No: 35688-09-6
    Price: Inquiry(

    Catalog No: CFN99826
    CAS No: 17526-15-7
    Price: Inquiry(

    Catalog No: CFN90394
    CAS No: 477-85-0
    Price: $278/20mg

    Catalog No: CFN97444
    CAS No: 87686-86-0
    Price: $286/5mg

    Catalog No: CFN96569
    CAS No: 644967-44-2
    Price: Inquiry(

    Catalog No: CFN80104
    CAS No: 80368-74-7
    Price: $463/5mg
    Mutat Res. 1996 Mar 1;367(3):123-33.
    Genotoxicity of aloeemodin in vitro and in vivo.[Pubmed: 8600368]
    The present in vitro and in vivo experiments were undertaken to clarify the genotoxic potential of the hydroxyanthrachinone Aloeemodin which can be found in different plant derived products for therapy of constipation.
    The results demonstrate that Aloeemodin is able to induce mutagenic effects in vitro. Positive results were obtained in the chromosomal aberration assay with CHO cells, as well as in the Salmonella reverse mutation assay (frameshift mutations in strains TA 1537, TA 1538 and TA 98). No mutagenic potential of Aloeemodin, however, was observed in the gene mutation assay with mammalian cells in vitro (HPRT assay in V79 cells). Each assay was performed in the presence and absence of an extrinsic metabolic activation system (S9-mix). In in vivo studies (micronucleus assay in bone marrow cells of NMRI mice; chromosome aberration assay in bone marrow cells of Wistar rats; mouse spot text [DBA/2JxNMRI]) no indication of a mutagenic activity of Aloeemodin was found. Information about a possible reaction of Aloeemodin with DNA was derived from an in vivo UDS assay. Hepatocytes of Aloeemodin-treated male Wistar rats did not show DNA damage via repair synthesis.
    All these data suggest that Aloeemodin is able to interact with DNA under certain in vitro conditions. However, in vivo the results that were negative did not indicate a genotoxic potential. Therefore, it may be assumed that a genotoxic risk for man might be unlikely.
    Curr Alzheimer Res. 2015;12(5):424-33.
    Inhibition of β-Amyloid Aggregation by Albiflorin, Aloeemodin and Neohesperidin and their Neuroprotective Effect on Primary Hippocampal Cells Against β-Amyloid Induced Toxicity.[Pubmed: 25938872]
    Being one of the hallmarks of Alzheimer's disease, β-amyloid (Aβ) aggregates induce complicated neurotoxicity. Evidences show that the underlying mechanism of neurotoxicity involves a glutamate receptor subtype, N-methyl-D-aspartate (NMDA) receptor, an increase in intracellular calcium(II) ion loading as well as an elevation in oxidation stress.
    In this work, among the 35 chemical components of Chinese herbal medicines (CHMs) being screened for inhibitors of Aβ aggregation, four of them, namely albiflorin, Aloeemodin, neohesperidin and physcion, were found for the first time to exhibit a potent inhibitory effect on Aβ(1-40) and Aβ(1-42) aggregation. Their neuroprotective capability on primary hippocampal neuronal cells was also investigated by MTT assay, ROS assay and intracellular calcium(II) ion concentration measurement.
    It was interesting to find that physcion was rather toxic to neuronal cells while albiflorin, Aloeemodin and neohesperidin reduced the toxicity and ROS induced by both monomeric and oligomeric Aβ species. In addition, albiflorin was particularly powerful in maintaining the intracellular Ca(2+) concentration.
    World Chinese Journal of Digestology, 2009, 17(27):2778-83.
    Effects of combined use of aloeemodin and praziquantel on the transforming growth factor-β/Smad pathway in mice with schistosomiasis-induced liver fibrosis.[Reference: WebLink]
    To investigate the effects of combined use of Aloeemodin and praziquantel on the transforming growth factor-β (TGF-β)/Smad pathway in mice with schistosomiasis-induced liver fibrosis.
    Eighty mice were randomly divided into four groups: normal control group, infection group, praziquantel treatment group, and praziquantel and Aloeemodin treatment group. Mice in the infection group and the two treatment groups were infected with 25 Schistosoma japonicum cercariae. Eight weeks after infection, mice in the praziquantel treatment group were treated with praziquantel at a dose of 500 mg/(kg·d) for two days, while those in the praziquantel and Aloeemodin treatment group were treated with praziquantel at the same dose for the same duration followed by treatment with Aloeemodin at a dose of 0.3 mg/(kg·d) for 8 weeks. At week 16, all mice were sacrificed to take liver tissue samples. Hematoxylin and eosin staining was performed to observe changes in hepatic histopathology. Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect the expression of Smad2 and Smad7 mRNAs in the liver. Immunohistochemical staining was performed to detect the expression of TGF-β1, TIMP-1, and type I and III collagen in liver tissue. Aloeemodin treatment relieved the degree of hepatic fibrosis. The expression levels of Smad2 mRNA and TGF-β1, tissue inhibitor of metalloproteinases-1 (TIMP1), and type I and III collagen proteins in liver tissue were significantly lower in the praziquantel and Aloeemodin treatment group than in the infection group and the praziquantel treatment group (q = 6.20 and 4.38, 6.22 and 4.41, 6.30 and 4.52, 6.25 and 4.44. and 6.29 and 4.48, respectively; all P < 0.01 or 0.05). In contrast, the expression level of Smad7 mRNA was significantly higher in the praziquantel and Aloeemodin treatment group than in the infection group and the praziquantel treatment group (q = 6.32 and 4.62, respectively; P < 0.01 and 0.05, respectively).
    Aloeemodin exerts anti-fibrotic effects perhaps through downregulation of the expression of Smad2 mRNA and TGF-β1, TIMP1, and type I and III collagen proteins, and upregulation of the expression of Smad7 mRNA.
    J. Modern Oncol., 2008, 16(06):919-21.
    Effects of aloeemodin on proliferation cycle and apoptotic of human stomach cancer cell line HGC-27.[Reference: WebLink]
    To study the suppressive role of Aloeemodin on the growth and its effect on the proliferation cycle and apoptosis of human stomach cancer cell line HGC-27.
    The survival rate and the inhibitory rate of HGC-27 cell in vitro were detected by MTT colorimetrie assay and cell growth curve assay at different time points under different concentration of Aloeemodin;the cell proliferation cycle and the apoptotic rate were examined with flow cytometry analysis.Aloeemodin inhibited the proliferation of HGC-27 cell at G0/G1 phase,decreased the cell ratio at S phase.It suppressed the growth of tumor cells and raised the apoptotic rate in a concentration and time depending manner in a certain extent.
    Aloeemodin could suppress the proliferation of HGC-27 cell to induce apoptosis and block cell cycle.
    Chinese Journal of Integrated Traditional & Western Medicine on Liver Diseases, 2012, 22(02):107-9.
    Effect of aloeemodin on liver fibrosis induced by Schistosoma Japonicum infections in mice.[Reference: WebLink]
    To observe the effect of Aloeemodin on liver fibrosis mice in duced by Schistosoma Japonicum.
    Mice' liver fibrosis model was induced by Schistosoma Japonicum infection for 8 weeks.Suspension of Aloeemodin prepared with normal saline was given orally to the mice,0.3 mg per mouse every day for 8 weeks.The level of malondialdehyde(MDA) in liver homogenate was detected.The level of transforming growth factor beta 1(TGF-β1),vascular endothelial growth factor(VEGF),Focal adhesion kinase(FAK) and type Ⅰ,Ⅲ collagen in liver tissue were detected by immuno-histochemistry.The pathological changes of liver tissue was inpreved by Aloeemodin.The level of type Ⅰand Ⅲ collagen in schistosomiasis liver fibrosis mice were decreased.TGF-β1,VEGF and FAK expression levels were increased in liver fibrosis induced by Schistosoma Japonicum.However,TGF-β1,VEGF and FAK expression were inhibited after administration of Aloeemodin.
    Aloeemodin might have therapeutic effects on liver fibrosis induced by Schistosoma of liver through the effects of TGF-β1,VEGF and FAK expression.
    Ganoderol A

    Catalog No: CFN99065
    CAS No: 104700-97-2
    Price: $488/5mg

    Catalog No: CFN99131
    CAS No: 23513-08-8
    Price: $168/20mg

    Catalog No: CFN99136
    CAS No: 486-62-4
    Price: $148/20mg
    Brevilin A

    Catalog No: CFN99694
    CAS No: 16503-32-5
    Price: $218/10mg

    Catalog No: CFN92224
    CAS No: 905954-17-8
    Price: $338/5mg

    Catalog No: CFN90742
    CAS No: 510-77-0
    Price: $318/10mg
    Bruceine E

    Catalog No: CFN89340
    CAS No: 21586-90-3
    Price: $318/5mg
    Epimagnolin A

    Catalog No: CFN90949
    CAS No: 41689-51-4
    Price: $268/10mg

    Catalog No: CFN95041
    CAS No: 80229-08-9
    Price: $418/5mg
    Licoricesaponin H2

    Catalog No: CFN95173
    CAS No: 118441-85-3
    Price: $218/10mg